Pharmaceutical and In-vitro Diagnostics Spend Analysis 2018 - 2019

Publication Date: November 2020

Download

The Procurement Services Branch (PSB) performs an annual analysis of UNFPA Pharmaceutical and In-vitro Diagnostics Spend.

Related content

Resources
The Expert Review Panel (ERP) assesses the potential risks/benefits associated with the use of the medicines submitted and advises UNFPA on its decision on whether to procure these products.
Resources
The list contains manufacturing sites that have been found to meet the requirements of the WHO/UNFPA Male Latex Condom: Specification, Prequalification and Guidelines for Procurement, 2010 and ISO 4074 Standard.
Resources

UNFPA Procurement Contract Awards from January 2021 until March 2021. Note that transactions that have been classified as a potential security risk for UNFPA County Offices or vendors have been removed from this list.

See all Procurement Contract Awards.  

Pages

We use cookies and other identifiers to help improve your online experience. By using our website you agree to this. To learn more, including how to change your settings, see our cookies policy.

X